Login / Signup

Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.

Hjalmar FlygtStina SöderlundJohan RichterSusanne SausselePerttu KoskenvesaLeif StenkeMohamed El MissiryAndreja DimitrijevicJesper StentoftWaleed MajeedLydia RoyDominik WolfArta DreimaneBjørn Tore GjertsenTobias Gedde-DahlErik AhlstrandBerit MarkevärnHenrik Hjorth-HansenJeroen JanssenUlla Olsson-Strömberg
Published in: Leukemia (2024)
Keyphrases
  • chronic myeloid leukemia
  • clinical trial
  • study protocol
  • phase iii
  • randomized controlled trial
  • phase ii
  • systemic lupus erythematosus
  • tyrosine kinase